Due to the fact that deficiencies in the co-stimulatory molecules CD80 and CD86 have been shown to reduce atherosclerosis in mice (32), the surface expression of CD80 molecule on HUVECs was evaluated in the present study by assessing the MFI. This evidence concerns the gene CD86 and atherosclerosis.